Clinical Trial

A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will be conducted to compare the efficacy, safety and patient-reported outcome of GZR4 and Insulin Icodec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2025-11-20
Trial Details
NCT Number NCT07165223
Lead Sponsor Gan & Lee Pharmaceuticals.
Conditions Diabetes
Enrollment 300 participants
Start Date 2025-10-17
Primary Completion 2026-11-10 (estimated)
Study Completion 2026-11-10 (estimated)
Updated on ClinicalTrials.gov 2025-11-25